On Air Now

Now Playing

Our Playlist »

Listen

Listen Live Now » 103.7 FM Sioux Falls, SD

Weather

Current Conditions(Sioux Falls,SD 57104)

More Weather »
31° Feels Like: 17°
Wind: NNE 26 mph Past 24 hrs - Precip: 0.06”
Current Radar for Zip

Tonight

Snow Showers/Wind Early 25°

Tomorrow

Mostly Sunny 50°

Thurs Night

Snow Showers Late 31°

Alerts

GSK's Tafinlar named as FDA breakthrough therapy for lung cancer

The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song
The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song

LONDON (Reuters) - British pharmaceutical company GlaxoSmithKline said its Tafinlar cancer treatment had been given FDA breakthrough therapy designation for lung cancer, meaning the drug will be fast-tracked within the U.S. regulatory system.

GSK said that Tafinlar, also known as dabrafenib, was designated an FDA breakthrough therapy on Monday following interim results from an ongoing Phase II study.

Tafinlar is already approved for melanoma, the deadliest form of skin cancer.

(Reporting by Sarah Young, Editing by Paul Sandle)

Comments